Roche NimbleGen Commits to GMP and FDA Submission for Microarrays

News   Apr 08, 2010

 
Roche NimbleGen Commits to GMP and FDA Submission for Microarrays
 
 
 

RELATED ARTICLES

Protein "Intentionally" Terminates own Synthesis by Destabilizing Synthesis Machinery — the Ribosome

News

A research group has discovered that a protein, during its synthesis, may destabilize the structure of the ribosome and end its own synthesis prematurely, and found that this phenomenon is used for adapting the cell to its environment.

READ MORE

What Makes Cancer Cells Metastasize?

News

Metastatic spread of tumor cells from one location in the body to another is the cause of 90 percent of cancer-related deaths.

READ MORE

Cell-weighing Method Could Help Doctors Choose Cancer Drugs

News

Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Microfluidics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE